Albuminuria screening seems not only effective but also cost-effective, when taking possible treatment with angiotensin-converting-enzyme (ACE) inhibitors into account, as it reduces the risk of both CKD and cardiovascular disease [28]. This evidence concerns the gene ACE and chronic kidney disease.